If you want to read our in-depth research articles or
have our amazing magazine delivered to your home
each month, then you have to pay.
We set cookies so you can manage your account and navigate the site, and to remember your cookie preferences so that you don't keep getting this message. To accept cookies, just keep browsing, otherwise use the links on the right to adjust your cookie settings or find out more.
The drugs industry has used 'statistical deception' to exaggerate the benefits of cholesterol-lowering statin drugs and down-play their risks, say researchers
It's been suspected for some time that cholesterol-lowering statin drugs cause cataracts-and now a major new study has almost conclusively proved they do.
Everyone over the age of 55 will soon be taking a cholesterol-lowering statin, doctors predict, after American heart specialists last week lowered the requirements for starting a prescription
Cholesterol-lowering statin drugs are doing more harm than good, and should be abandoned as the primary therapy for heart disease prevention, a major review has concluded
Another side-effect of cholesterol-lowering statin drugs has emerged: they increase the risk of cataracts
Doctors are being urged to choose the lowest-possible dose when they prescribe cholesterol-lowering statins after a study discovered the drugs cause a range of health problems, including serious liver and kidney failure